skip to content »

Section of Infectious Diseases

Houston, Texas

BCM pediatricians care for children in various clinical and hospital environments.
Section of Infectious Diseases
not shown on screen

Barbara W. Trautner, M.D., Ph.D.

Barbara W. Trautner, M.D., Ph.D.Assistant Professor, Department of Medicine
Program Director, Infectious Diseases Fellowship

Education

A.B., Princeton University, 1991
M.D., University of Virginia School of Medicine, 1995
Ph.D., Baylor Graduate School of Biomedical Sciences, 2007

Residency

Medical Resident, Internal Medicine, Baylor College of Medicine, 1995-1998
Chief Medical Resident, Internal Medicine, Baylor College of Medicine, 1998-1999

Fellowship

Infectious Diseases, Baylor College of Medicine, 1999-2002

Board Certification

Internal Medicine, Infectious Diseases

Specialty

Infectious Diseases, Internal Medicine

Research Interest

Dr. Trautner’s research interest is the development of new strategies for prevention of catheter-associated urinary tract infection. Her laboratory performs translational research investigating the use of benign bacteria to prevent symptomatic UTI with pathogens (bacterial interference). In clinical trials she utilizes urinary catheters coated with a biofilm of benign E. coli to achieve bladder colonization and possible protection from UTI. In vitro she studies the mechanisms of bacterial interference and biofilm formation by E. coli, with the goal of creating modified strains of E. coli for clinical use in prevention of UTI.

Publications

  1. Trautner BW, Darouiche RO. Tuberculous pericarditis: optimal diagnosis and management. Clinical Infectious Diseases 2001;33:954-61.
  2. Trautner BW, Darouiche RO, Hull RA, Hull S, Thornby JI. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. Journal of Urology 2002; 167:375-9.
  3. Trautner BW, Darouiche RO. Prevention of urinary tract infection in patients with spinal cord injury. The Journal of Spinal Cord Medicine 2002; 25:277-283.
  4. Trautner BW, Darouiche RO, Clarridge, JE. Skin disinfection kits containing chlorhexidine gluconate or tincture of iodine are associated with low rates of blood culture contamination. Infection Control and Hospital Epidemiology 2002; 23:397-401.
  5. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DM, Gathe JC, Visnegarawala F, Trautner BW. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine2002;81:213-7.
  6. Trautner BW, Hull RA, Darouiche RO. Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology 2003; 61:1059-1062.
  7. Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Archives of Internal Medicine 2004; 164:842-850.
  8. Trautner BW, Darouiche RO. The role of biofilm in catheter-associated urinary tract infection. American Journal of Infection Control 2004; 32:177-183.
  9. Trautner BW, Atmar RL, Hulstrom A, Darouiche RO. Inactivated influenza vaccination for persons with spinal cord injury. Archives of Physical Medicine and Rehabilitation, 2004: 85:1886-1889.
  10. Trautner BW, Hull RA, Darouiche RO. Prevention of catheter-associated urinary tract infection. Current Opinion in Infectious Disease 2005; 18:37-41.
  11. Trautner BW, Hull RA, Darouiche RO. Colicins prevent colonization of urinary catheters. Journal of Antimicrobial Chemotherapy, 2005; 56:413-15.
  12. Trautner BW, Caviness AC, Gerlacher GR, Demmler G, Macias CG. Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature > 106ºF). Pediatrics, 2006; 188: 34-40.
  13. Trautner BW, Hull RA, Thornby JI, Darouiche RO. Coating urinary catheters with an avirulent strain of Escherichia coli as a means to prevent recurrent symptomatic infection. Infection Control Hospital Epidemiology, 2007; 28: 92-94.
  14. Hung EH, Darouiche RO,Trautner BW. Proteus bacteriuria is associated with significant morbidity in spinal cord injury. Spinal Cord 2007; 45: 616-20.
  15. Trautner BW, Zimmermann KP, Squyers SA, Darouiche RO. Delayed hypersensitivity testing in persons with a history of cerebrovascular accident. Journal of Spinal Cord Medicine, 2007; 30: 362-65.
  16. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Combination of tigecycline and N acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrobial Agents and Chemotherapy, 2007; 51: 1556-8.
  17. Hussain R, Cevallos ME, Darouiche RO, Trautner BW. Gram-Negative Intravascular Catheter-Related Bacteremia in Spinal Cord Injury Patients. Archives of Physical Medicine & Rehabilitation, in press.

E-mail this page to a friend